Clinical Trials Browser

Phase 2 × penpulimab × 1 year × Clear all

NCT05807880 2026-01-23

ALTER-HN005

Phase 2 Active not recruiting

Nasopharyngeal Neoplasms

NCT05576480 2025-08-28

SPARC

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms